News and Announcements
YPB First Commercial Contract in Mexico
- Published August 24, 2016 2:44PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
24th August 2016, ASX Announcement
Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) has secured its first commercial contract in Mexico through its joint venture (JV) with Affyrmx Group.
The initial contract value is US$130,000, with YPB’s proprietary tracer solution to be used to PROTECT redeemable food coupons that are frequently the subject of counterfeit. The end client is actively engaged in programs supporting people in need.
Earlier this year YPB entered a JV with Affyrmx with an initial focus on Government Vital Documents in Mexico. To date YPB has received contracts to supply Vital Records to four Mexican states, with outstanding opportunities across all of the country’s 32 states, governing a population of more than 120 million.
While continuing to develop opportunities in the government sector Affyrmx is now actively pursuing deals in the commercial sector with YPB.
To read the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
